ArticleClinical oral investigations2025
Oral cancer in women: clinical profile, risk factors, treatment outcomes and survival predictors in 32 years of experience.
Article in Clinical oral investigations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAn increase in the incidence of oral cancer in women has been reported in some countries. This study investigated demographic, clinicopathological, risk factors, treatment outcomes and predictors for survival in female patients with oral cancer treated in a reference head and neck cancer center for the past 32 years.
methodsThis retrospective cohort study reviewed the clinical records of women patients with oral squamous cell carcinoma (OSCC). The proportion of OSCC cases in women relative to men over the last three decades was investigated. Clinicopathological data were correlated with treatment outcomes using logistic regression analysis. The 2 and 5-year overall survival (OS) and disease-specific survival (DSS) were assessed through the Kaplan-Meier and Cox regression analyses.
resultsIn total, 133 women patients with OSCC were investigated. The ratio of oral cancer cases in women to men has almost doubled in the last decade. Most female patients were non-smokers (51.9%) and non-alcoholics (69.2%) and had early-stage disease at the time of diagnosis (51.9%). The most frequent tumor sites were tongue (46.6%) and alveolar ridge (18%). Advanced clinical stage was the independent predictor for worse 5-year OS (p < 0.001) and DSS (p < 0.001), while non-surgical treatment was associated with poor OS only at the 2-year cutoff (p = 0.003).
conclusionThis study demonstrates an increase in the proportion of oral cancer cases in women in the last decade. Advanced-stage tumors remain the main predictor for women with oral cancer, denoting the need to strengthen policies to increase the rate of early diagnosis for this population. CLINICAL RELEVANCE: The number of female patients with oral cancer without the classic risk factors for the disease has been increasing over the years. Clinicians should be alerted to ulcerated lesions in the oral mucosa of non-smoking and non-alcoholic women, favoring early diagnosis.
Indexed as
Identifiers
41369882What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.